Field Safety Notices: 5 to 9 May 2025
List of Field Safety Notices from 5 to 9 May 2025.
List of Field Safety Notices from 5 to 9 May 2025.
Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on certain batches of Fexofenadine Hydrochloride 120mg film-coated tablets, distributed by Healthcare Pharma Limited.
List of Field Safety Notices from 11 to 15 August 2025.
Parents and caregivers who have purchased Nutrition Ignition Kids Magnesium Glycinate Gummies should stop giving them to children and safely dispose of any remaining product. It is recommended that advice be sought from a healthcare professional if a child has any side effects that are of concern.
As with any medicine, the MHRA will keep the safety and effectiveness of teplizumab under close review.
Use this form to transfer a product licence, also known as a marketing authorisation, to a different owner.
Accord Healthcare Limited, UK has informed the MHRA that the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) do not contain all the required safety information.
Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.
List of Field Safety Notices from 4 to 8 August 2025.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
The MHRA invites health institutions in Great Britain to share their experience of the health institution exemption (sometimes referred to as an in-house manufacturing exemption).